ArticleCancer cell international2022

Multiomics surface receptor profiling of the NCI-60 tumor cell panel uncovers novel theranostics for cancer immunotherapy.

Simon Heumos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.